Table 5 Treatment-related adverse events
Events, n (%) | Any grade | ≥ Grade3 |
|---|---|---|
Myelosuppression | 7 (14.3%) | 5 (10.2%) |
Fever | 5 (10.2%) | 0 |
Pneumonia | 4 (8.2%) | 0 |
Abnormal liver function | 4 (8.2%) | 1 (2.0%) |
Telangiectasia | 4 (8.2%) | 0 |
Hypothyroidism | 3 (6.1%) | 0 |
Fatigue | 2 (4.1%) | 0 |
Hyperuricemia | 2 (4.1%) | 2 (4.1%) |
Anemia | 2 (4.1%) | 0 |
Myocarditis | 2 (4.1%) | 0 |
Enteritis | 1 (2.0%) | 0 |
Impaired pituitary function | 1 (2.0%) | 0 |
Hypokalemia | 1 (2.0%) | 0 |
Thrombocytopenia | 1 (2.0%) | 1 (2.0%) |
Febrile neutropenia | 1 (2.0%) | 1 (2.0%) |
Diarrhea | 1 (2.0%) | 0 |
Hyperglycemia | 1 (2.0%) | 0 |
Elevated troponin T | 1 (2.0%) | 0 |
Thyroiditis | 1 (2.0%) | 0 |
Nausea | 1 (2.0%) | 0 |
Loss of appetite | 1 (2.0%) | 0 |
Vomiting | 1 (2.0%) | 0 |
Rash/itching | 1 (2.0%) | 0 |
Allergic reaction | 1 (2.0%) | 0 |